![](/img/cover-not-exists.png)
A phase I trial of topotecan and gemcitabine administered weekly for 3 consecutive weeks to patients with advanced tumors
Weijing Sun, James P. Stevenson, Maryann Gallagher, Bruce Giantonio, Kenneth Algazy, Dan Haller, David Vaughn, Barbara J. Raskay, Peter J. O'DwyerVolume:
92
Year:
2001
Language:
english
Pages:
6
DOI:
10.1002/1097-0142(20010715)92:23.0.co;2-w
File:
PDF, 72 KB
english, 2001